Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

NCT05981001 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

PROCEDURE: Surgery for harvesting tumor-draining lymph nodes
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Tumor-draining lymph node-derived lymphocyte (LNL)
BIOLOGICAL: Interleukin-2
BIOLOGICAL: Camrelizumab
DRUG: Nab-paclitaxel
DRUG: Gemcitabine
DRUG: Carboplatin

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University